Long-term follow-up from the OITI trial: ponatinib in patients with CML in Italy
Massimo Breccia • 13 Jun 2023
Phase II study of all-oral AAA regimen for patients with newly diagnosed APL
Harinder Gill • 10 Jun 2023
Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.